Bio21's Michael Parker is part of an international collaboration that has shown how the bacteria Gardnerella vaginalis targets cells and causes infection in women
The Honourable Frank McGuire, Jan Tennent, CEO of BioMedVic and Professor Ian Gust, former Head of CSL’s Research and Development division, in the Bio21 atrium.